Request to Join
has invited you to join this group
Dr. Melinda Telli is an Assistant Professor of Medicine in the Division of Medical Oncology at Stanford with a clinical and research focus in breast cancer. Dr. Telli's primary research focus is the development of novel therapeutic strategies for the treatment of triple-negative and BRCA1/2 mutation-associated breast cancer. She is interested in the conduct of studies in early breast cancer that incorporate predictive biomarkers of response to therapy and their translation into clinical care. Other interests include cardiotoxicity of anti-cancer therapies and medical education.
Dr. Hughes is a member of the Department of Surgical Oncology at the Massachusetts General Hospital and a graduate of Dartmouth College and Dartmouth Medical School. He trained at the Mercy Hospital of Pittsburgh for general surgery, followed by a fellowship in surgical oncology at the National Cancer Institute. Dr. Hughes was formerly on the faculty of Tufts University, the University of California, Davis and Brown University. Dr. Hughes is actively involved in clinical care and research related to the genetics, screening, diagnosis and treatment of breast cancer and is actively involved in the development of Health Information Technology that improves quality while decreasing clinician workload. He co-authored the HL7, ANSI approved standard for transmitting family health history, and was the Principal Investigator for the Cooperative Group Trial (CALGB 9343) that showed radiation therapy had little benefit in women over age 70 with early breast cancer.
He is the co-creator of
Clinical Decision Support Tool that calculates risk for patients with cancer susceptibility gene mutations.